560 related articles for article (PubMed ID: 18578473)
21. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
A Malik A; Dangroo NA; Kaur P; Attery S; A Rather M; Khan A; Ara T; Nandanwar H
Microb Pathog; 2024 May; 190():106627. PubMed ID: 38521473
[TBL] [Abstract][Full Text] [Related]
22. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
[TBL] [Abstract][Full Text] [Related]
23. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
[TBL] [Abstract][Full Text] [Related]
24. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ
Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124
[TBL] [Abstract][Full Text] [Related]
26. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
[TBL] [Abstract][Full Text] [Related]
27. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
[TBL] [Abstract][Full Text] [Related]
28. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
29. Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
Pereda-Miranda R; Kaatz GW; Gibbons S
J Nat Prod; 2006 Mar; 69(3):406-9. PubMed ID: 16562846
[TBL] [Abstract][Full Text] [Related]
30. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A
J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747
[TBL] [Abstract][Full Text] [Related]
31. 3-Aryl-4-methyl-2-quinolones targeting multiresistant Staphylococcus aureus bacteria.
Doléans-Jordheim A; Veron JB; Fendrich O; Bergeron E; Montagut-Romans A; Wong YS; Furdui B; Freney J; Dumontet C; Boumendjel A
ChemMedChem; 2013 Apr; 8(4):652-7. PubMed ID: 23436688
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
34. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
Pereira PS; Lima MDCA; Neto PPM; Oliveira-Tintino CDM; Tintino SR; Menezes IRA; de Oliveira JF; Marchand P; Coutinho HDM; Rodrigues MDD; da Silva TG
Bioorg Med Chem; 2019 Sep; 27(17):3797-3804. PubMed ID: 31320212
[TBL] [Abstract][Full Text] [Related]
35. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
[TBL] [Abstract][Full Text] [Related]
37. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
[TBL] [Abstract][Full Text] [Related]
38. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.
Felicetti T; Cedraro N; Astolfi A; Cernicchi G; Mangiaterra G; Vaiasicca S; Massari S; Manfroni G; Barreca ML; Tabarrini O; Biavasco F; Cecchetti V; Vignaroli C; Sabatini S
Eur J Med Chem; 2022 Nov; 241():114656. PubMed ID: 35963131
[TBL] [Abstract][Full Text] [Related]
39. Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.
Ponnusamy K; Ramasamy M; Savarimuthu I; Paulraj MG
Scand J Infect Dis; 2010 Jul; 42(6-7):500-5. PubMed ID: 20380543
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.
Takács D; Cerca P; Martins A; Riedl Z; Hajós G; Molnár J; Viveiros M; Couto I; Amaral L
In Vivo; 2011; 25(5):719-24. PubMed ID: 21753124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
